Personnel changes have taken place at Akrikhin: a new commercial director and vice president for generic drugs have been appointed. This is stated in the company's message.
In order to implement the strategic plans of AKRIKHIn, a new commercial director, Alexander Sokolov, was appointed. In this position, he reports to the company's president Denis Chetverikov.
Another appointment in the company is due to the fact that in 2023 the direction of generic drugs "Akrikhina" is allocated to an independent business unit - the sales and marketing service of generic drugs. The business unit was headed by Lydia Choborovskaya, Vice President for Generic Drugs, with direct subordination to Denis Chetverikov, President of the company.
Akrikhin is one of the Russian pharmaceutical companies that produces medicines of the therapeutic groups most in demand by patients. The company's product portfolio includes about 200 drugs, more than 45% of which are included in the list of vital and essential medicines (VED).
